In a recent news release, AbbVie Company of Allergan Aesthetics announced the U.S. FDA approval of their injectable skin-hydrating product, Juvederm Skinvive. A new member of the Juvéderm collection, Juvederm Skinvive is unique, the first aesthetic treatment that increases skin smoothness by injecting a hyaluronic acid-based gel into the dermal layer of skin. An optimal treatment for improving skin hydration and quality for all FitzPatrick skin types, Juvederm Skinvive is only minimally invasive. It requires no downtime following the treatment with results that work. After clinical trials run by lead investigators, researchers found that most patients saw a significant improvement in skin hydration and smoothness up to six months after receiving the injection. Juvederm Skinvive is predicted to become commercially available within the next six months to experienced Juvederm injectors.
One healthcare provider always on the cutting edge of new, effective treatments is expert board-certified dermatologist Dr. Michele Green. Constantly seeking out the most effective and safest treatment options for her patients, Dr. Green is highly experienced in various cosmetic and medical treatments, including dermal fillers, Botox, Kybella, laser treatments, chemical peels, and more. Dr. Green is an expert in helping patients with skincare concerns. She has her proprietary line of skincare products, MGSKINLABs, which allows her to recommend the highest quality products to her patients. Well-known for high patient satisfaction, Dr. Green has been voted one of the best healthcare providers in New York City by such publications as Castle Connolly, New York Magazine, and Super Doctors.
What is Skinvive?
Skinvive is a new, innovative injectable treatment to hydrate and smooth the skin of the cheeks. Developed by AbbVie Company of Allergan Aesthetics, Juvederm Skinvive works differently from the dermal fillers that make up the current Juvéderm collection. Juvederm dermal fillers can be used to replace lost volume at the treatment area, contour the face and jawline, or fill in fine lines and wrinkles for an overall more youthful appearance. Like Juvederm fillers, Juvederm Skinvive is an injectable gel composed of hyaluronic acid. However, Skinvive differs from dermal fillers in its use: to increase skin hydration and smoothness near the injection site. After a clinical study where the product was tested on human skin to determine the safety and effectiveness of the treatment, Juvederm Skinvive received U.S. FDA approval, meaning it will become available for use by experienced clinicians and injectors within the next six months.
What is Skinvive used for?
Skinvive represents an innovation in the field of cosmetic dermatology, as it is the first intradermal injectable hyaluronic acid-based treatment to improve skin texture for smooth, hydrated skin. The injectable treatment is specifically used to combat dry skin in the cheek area of the face. One great advantage of the Juvederm Skinvive injections is that they can be safely used on patients of all skin types on the FitzPatrick scale. The treatment results in improved skin quality, manifesting as more hydrated-looking skin and patients feeling more radiant and refreshed.
How does Skinvive work?
Patients who feel dissatisfied with the quality of their skin may not realize that to have healthy, glowing, vibrantly smooth skin, the skin needs to be thoroughly hydrated. Skinvive comprises hyaluronic acid, a naturally occurring substance in the body that binds water molecules to keep the skin plump and hydrated. With an injection of the hyaluronic acid-based gel, Juvederm Skinvive treatment hydrates the skin, increasing skin smoothness. When injected hyaluronic acid into the treatment area, it also increases collagen production, which improves skin elasticity and can help to reduce the appearance of fine lines.
What is the procedure for Skinvive injectable gel treatment?
The first step for any cosmetic treatment is to schedule a consultation with expert board-certified dermatologist Dr. Michele Green at her Upper East Side New York City dermatology office. At the consultation, you will discuss your treatment needs and aesthetic goals, and Dr. Green will decide about the treatment or series of treatments that will best meet your needs. If you are dealing with dry skin on the cheeks, Skinvive injectable treatment may be your best option. When you arrive at the office for treatment, Dr. Green may apply a topical anesthetic to the skin at the injection site to improve patient comfort during the procedure. Skinvive also contains an anesthetic called lidocaine, ensuring patients feel minimal discomfort during treatment. The injections will be quick, and patients can immediately return to their regularly scheduled activities without downtime. Most patients experience mild side effects, such as swelling and discoloration at the injection site, which should resolve on their own within 30 days.
How long do results last?
The results of Skinvive skin hydrating treatment are long-lasting and become apparent after only one treatment session, meaning no additional treatment sessions are necessary until the effects of the treatment begin to wear off. According to the clinical trials, most patients still noted the revitalizing effects of the treatment six months after receiving the injections, meaning that the treatment results can be visible for at least six months. Once the effects of the treatment begin to fade, patients can schedule a maintenance appointment with Dr. Green for continued skin smoothness.
What are the side effects?
There are several common side effects that patients may experience after receiving the injections, which can include;
- Swelling at the injection site
- Bruising, redness, or discoloration
- Lumps, bumps, or firmness at or near the injection site
- Pain and tenderness
These side effects are typically mild, meaning they do not prevent patients from performing their regular activities, and they will typically resolve on their own within 30 days of receiving the treatment. Some patients also reported more moderate side effects, such as abrasions and papules at the injection site, though this is a more uncommon side effect. If side effects do not resolve within 30 days, it is best to contact your healthcare provider for treatment.
Is Skinvive treatment effective?
Clinical trials noted that Juvederm Skinvive is a safe and effective treatment for increasing skin hydration and smoothness. An evaluator-blind, controlled clinical study was performed to determine if Skinvive was safe for patients and performed its desired function. Patients were asked to rate their satisfaction with the treatment one month and six months after receiving the injections on various factors, including skin healthiness, hydration, and radiance. After six months, 63% of patients were satisfied with the radiance of their skin in the treatment area, compared to only 11% before the treatment began. Similarly, 83% of patients were satisfied with the health of their skin compared to 38% before treatment, and 72% were satisfied with facial hydration at six months compared to 24% pre-treatment. Juvederm Skinvive gained FDA approval in the United States following the trials, meaning that it was safe and effective for patients looking to achieve smooth, hydrated skin.
What is Skinviva vs Skinvive?
Patients looking for Skinvive hydrating skin treatment should be careful not to misspell the name to avoid being confused with Skinviva, a skin treatment clinic in Manchester, UK. If you have questions about what a Skinvive treatment is, it is always best to consult with an expert dermatologist, such as Dr. Green, who can give you all the information you need about treatment and recommend the procedure that will work best for you.
How soon until Skinvive treatment becomes available?
Juvederm Skinvive, produced by the AbbVie Company of Allergan Aesthetics, recently gained approval in the United States from the Food and Drug Administration (FDA) to treat dry, unevenly textured skin on the cheeks. The treatment is newly tested in clinical trials and is safe and effective for generating smooth, hydrated skin on the cheeks. As such, it will soon become available for general use – likely within the next six months. The company has stated that before injectors can use the product, they must attend training to familiarize themselves with the procedure. Dr. Green looks forward to becoming one of the first healthcare providers to receive training and make this unique treatment available at her New York City dermatology office.
How do I get started with skincare treatment today?
Juvederm Skinvive treatment will become available in about six months for commercial use and is a new, innovative solution for combatting dry skin on the cheeks. As the first-ever intradermal injectable hyaluronic acid gel, this unique cosmetic procedure will provide patients with smooth, hydrated, youthful-looking skin for at least six months post-treatment. As one of New York City’s leading dermatology professionals, Dr. Michele Green looks forward to adding Juvederm Skinvive to her arsenal of skincare treatments and products, providing patients with smooth, clear, radiant skin.
Dr. Michele Green is an internationally renowned board-certified cosmetic dermatologist with over two and a half decades of experience providing some of the world’s most discerning men and women with the best non-invasive aesthetic treatment options, including the latest dermal fillers. Utilizing the most cutting-edge treatments and innovative techniques, Dr. Green is consistently identified as one of New York City’s best dermatologists by Super Doctors, Castle Connolly, New York Magazine, and the New York Times for her dedication to her patients and expertise. Dr. Green takes a holistic approach and embraces a less-is-more philosophy regarding rejuvenation, customizing each patient’s treatment plan to incorporate a combination of specially formulated skincare products and non-invasive aesthetic treatments that best suits their specific skin concerns and unique cosmetic goals. Please get in touch with us online today to schedule a private consultation with Dr. Green in her discreet boutique New York office, or call 212-535-3088.